Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)

PHASE3CompletedINTERVENTIONAL
Enrollment

554

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

April 27, 2020

Study Completion Date

April 27, 2020

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

ThermoDox

Thermally Sensitive Liposomal Doxorubicin 50 mg/m2 Single 30 minute intravenous infusion

DRUG

Dummy infusion

Sodium Chloride 0.9% or 5% Dextrose (D5W), Single 30 minute intravenous infusion

Trial Locations (61)

100

National Taiwan University Hospital, Taipei

235

Taipei Medical University-Shuang Ho Hospital, New Taipei City

333

Chang Gung Memorial Hospital - Linkou, Taoyuan District

407

Taichung Veteran General Hospital, Taichung

640

National Taiwan University Hospital, Yun-Lin Branch, Yuanlin

704

National Cheng Kung University (NCKU) Hospital, Tainan City

833

Chang Gung Memorial Hospital - Kaohsiung, Kaohsiung City

1003

Chinese General Hospital and Medical Center, Manila

1112

St. Lukes Medical Center, Quezon City

1503

Cardinal Santos Medical Center, San Juan City

10700

Siriraj Hospital, Bangkok

12120

Thammasat University Hospital, Pathum Thani

40002

Srinagarind Hospital, Khon Kaen

59100

University Malaya Medical Centre, Kuala Lumpur

66421

Universitaetsklinikum des Saarlandes, Klik fuer Allgemeine Chirurgie, Viszeral-, Gefaess und Kinderchirurgie, Homburg

90095

UCLA Department of Medicine, Los Angeles

90110

Songklanagarind Hospital, Songkhla

100034

Peking University First Hospital, Beijing

100036

Beijing Cancer Hospital, School of Oncology, Peking, Beijing

100039

302 Military Hospital of China, Beijing

100730

Beijing Hospital of the Ministry of Health, Beijing

110006

The Sixth People's Hospital of Shenyang, Shenyang

116023

The Second Hospital of Dalian Medical University, Dalian

130021

The First Hospital of Jilin University, Jilin

169608

Singapore General Hospital, Singapore

200032

Zhongshan Hospital, Fudan University, Shanghai

300170

The 3rd Hospital of Tianjing, Tianjin

310013

The First Hospital of Zhejiang, Zhejiang

310022

Zhejiang Cancer Hospital, Zhejiang

350005

Mengchao Hepatobiliary Hospital of Fujian Medicatl University, Fuzhou

410013

Hunan Cancer Hospital, Hunan

510080

Guangdong General Hospital, Guangdong

610041

West China Hospital of Sichuan University, Chengdu

710032

Xijing Hospital, Xi'an

Unknown

Toronto General Hospital, Toronto

Chinese PLA General Hospital, Beijing

Institut für Diagnostische und Radiologische Therapie del Uniklinik Frankfurt, Frankfurt

Klinikum rechts der Isar, II. Medizinische Klinik und Poliklinik (Gastroenterologie), München

Universitätsklinikum Regensburg, Institut für Röntgendiagnostik, Regensburg

Queen Mary Hospital, Hong Kong

Cisanello Hospital, Division of Diagnostic Imaging and Intervention, Pisa

"Department of Radiological Sciences and Bioimaging Catholic University of Rome, A. Gemelli Hospital", Rome

Hospital Madrid Norte Sanchinarro, Madrid

Hospital Universitario Marqués de Valdecilla, Santander

Maharaj Nakorn Chiang Mai Hospital, Chiang Mai

Bach Mai Hospital, Hà Nội

108 Military Central Hospital, Hà Nội

Hue Central Hospital, Huế

Bach Mai Hospital (Hepato-gastroenterology Department), Hanoi

Can Tho Oncology Hospital, Hanoi

National Cancer Hospital, Hanoi

Viet Duc University Hospital, Hanoi

People's Hospital 115, Ho Chi Minh City

602-739

Pusan National University Hospital, Busan

700-721

Kyungpook National University Hospital, Daegu

702-210

Kyungpook National University Medical Center, Daegu

400-711

Inha University Hospital, Incheon

110-744

Seoul National University Hospital, Seoul

120-752

Severance Hospital, Yonsei University Health System, Seoul

135-710

Samsung Medical Center, Seoul

137-701

The Catholic University of Korea, Seoul St.Mary's Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Imunon

INDUSTRY

NCT02112656 - Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) | Biotech Hunter | Biotech Hunter